258 related articles for article (PubMed ID: 28346088)
1. A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids.
Madoux F; Tanner A; Vessels M; Willetts L; Hou S; Scampavia L; Spicer TP
SLAS Discov; 2017 Jun; 22(5):516-524. PubMed ID: 28346088
[TBL] [Abstract][Full Text] [Related]
2. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
[TBL] [Abstract][Full Text] [Related]
3. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates.
Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA
Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502
[TBL] [Abstract][Full Text] [Related]
4. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
[TBL] [Abstract][Full Text] [Related]
5. Real-Time Apoptosis and Viability High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Qiu J; Chan LL
SLAS Discov; 2018 Feb; 23(2):202-210. PubMed ID: 28915356
[TBL] [Abstract][Full Text] [Related]
6. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of Uniform Spheroid Formation in 384-Well Plates: The Effect of Medium Evaporation.
Das V; Fürst T; Gurská S; Džubák P; Hajdúch M
J Biomol Screen; 2016 Oct; 21(9):923-30. PubMed ID: 27226477
[TBL] [Abstract][Full Text] [Related]
8. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.
Howes AL; Richardson RD; Finlay D; Vuori K
PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711
[TBL] [Abstract][Full Text] [Related]
9. Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening.
Hou S; Tiriac H; Sridharan BP; Scampavia L; Madoux F; Seldin J; Souza GR; Watson D; Tuveson D; Spicer TP
SLAS Discov; 2018 Jul; 23(6):574-584. PubMed ID: 29673279
[TBL] [Abstract][Full Text] [Related]
10. A simple, reliable method for high-throughput screening for diabetes drugs using 3D β-cell spheroids.
Amin J; Ramachandran K; Williams SJ; Lee A; Novikova L; Stehno-Bittel L
J Pharmacol Toxicol Methods; 2016; 82():83-89. PubMed ID: 27554916
[TBL] [Abstract][Full Text] [Related]
11. Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres.
Ivanov DP; Parker TL; Walker DA; Alexander C; Ashford MB; Gellert PR; Garnett MC
PLoS One; 2014; 9(8):e103817. PubMed ID: 25119185
[TBL] [Abstract][Full Text] [Related]
12. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.
Sirenko O; Mitlo T; Hesley J; Luke S; Owens W; Cromwell EF
Assay Drug Dev Technol; 2015 Sep; 13(7):402-14. PubMed ID: 26317884
[TBL] [Abstract][Full Text] [Related]
13. The Influence of Antitumor Unsymmetrical Bisacridines on 3D Cancer Spheroids Growth and Viability.
Kulesza J; Pawłowska M; Augustin E
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684841
[TBL] [Abstract][Full Text] [Related]
14. Fully Automated One-Step Production of Functional 3D Tumor Spheroids for High-Content Screening.
Monjaret F; Fernandes M; Duchemin-Pelletier E; Argento A; Degot S; Young J
J Lab Autom; 2016 Apr; 21(2):268-80. PubMed ID: 26385905
[TBL] [Abstract][Full Text] [Related]
15. 3D Models of the NCI60 Cell Lines for Screening Oncology Compounds.
Selby M; Delosh R; Laudeman J; Ogle C; Reinhart R; Silvers T; Lawrence S; Kinders R; Parchment R; Teicher BA; Evans DM
SLAS Discov; 2017 Jun; 22(5):473-483. PubMed ID: 28288283
[TBL] [Abstract][Full Text] [Related]
16. Exploring Drug Dosing Regimens In Vitro Using Real-Time 3D Spheroid Tumor Growth Assays.
Lal-Nag M; McGee L; Titus SA; Brimacombe K; Michael S; Sittampalam G; Ferrer M
SLAS Discov; 2017 Jun; 22(5):537-546. PubMed ID: 28298153
[TBL] [Abstract][Full Text] [Related]
17. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array.
Tung YC; Hsiao AY; Allen SG; Torisawa YS; Ho M; Takayama S
Analyst; 2011 Feb; 136(3):473-8. PubMed ID: 20967331
[TBL] [Abstract][Full Text] [Related]
18. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
[TBL] [Abstract][Full Text] [Related]
19. Single and Combination Drug Screening with Aqueous Biphasic Tumor Spheroids.
Shahi Thakuri P; Tavana H
SLAS Discov; 2017 Jun; 22(5):507-515. PubMed ID: 28324660
[TBL] [Abstract][Full Text] [Related]
20. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen.
Li Q; Chen C; Kapadia A; Zhou Q; Harper MK; Schaack J; LaBarbera DV
J Biomol Screen; 2011 Feb; 16(2):141-54. PubMed ID: 21297102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
